Almost every week we hear of a new genome sequence being completed, yet turning sequence information into knowledge about what individual genes do is very difficult. An article published in Journal of Biology this week will simplify this task, as it describes a new online tool that dramatically improves predictions of how individual genes are regulated.
Dr. Wyeth Wasserman and his team have created this powerful new two-step method for identifying which regulators of gene expression, called transcription factors, are in control of individual genes. The new method is far more selective than its predecessors, reducing the number of biologically irrelevant transcription factors identified in a search by 85%. The researchers have now made the tool available through an easy to use website called ConSite.
This web-based tool will be particularly helpful in analysing genes whose coding sequences do not give any clues as to their function. Around 30% of the predicted human genes contain no recognisable domains. Through knowing which transcription factors control the expression of a particular gene, scientists can get an idea as to what processes the gene is involved in. This is because transcription factors are themselves tightly controlled to ensure that a gene is only expressed when and where it is needed, and a great deal is already known about which events activate which transcription factors.
"Knowledge of the identity of a mediating transcription factor can give important insights into the function of a gene," according to the authors of the article.
Transcription factors act by binding to specific sequences in a regulatory region that is located in the DNA upstream of the coding region. But they can tolerate a large amount of variation in these sequences. This means that searching an upstream regulatory region for transcription factor binding sites identifies a large number of such sites, most of which are biologically irrelevant.
The researchers successfully increased the signal to noise ratio of such searches by using a powerful combination of two methods. Firstly, the regulatory sequences are scanned for binding sites, but only for those that are known to be biologically active. For this comparison, Wassermans team compiled a searchable database of 108 transcription factor binding profiles from the relevant literature. The sites listed originate from mammals, insects and nematodes, and all are supported by good experimental evidence. These experiments provide essential information about the in vivo properties necessary for binding that are not contained in the sequence alone.
Secondly, the researchers use an alignment tool to compare the regulatory sequences of the same gene from two different species, and check which sites are conserved across evolution. "The most valuable information in the search for regulatory regions in genomic sequences is conservation. If a region is found to be conserved between a human genomic sequence and an orthologous genomic sequence from a distantly related organism, it is extremely likely to have a biological role," write the authors.
To test their two-step method, the researchers used it to identify the transcription factors that bind to the upstream regulatory regions of 14 well-studied genes. Using human and mouse sequences, the researchers found that all of the transcription factors identified did have a biological role and only a few of the physiologically relevant regulators were missed. A second test showed that the evolutionary distance between the two input sequences was vital in determining the effectiveness of the combined method.
This tool is now available to all scientists free of charge via the ConSite website: http://www.phylofoot.org/ Any scientist with a gene of interest will be able to input the regulatory sequence of their pet gene with or without the regulatory sequence of an orthologous gene into the ConSite tool, and will be rewarded with a list of probable regulators.
From a plant sugar to toxic hydrogen sulfide
19.12.2018 | Universität Konstanz
Gut microbiome regulates the intestinal immune system, researchers find
19.12.2018 | Brown University
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Information Technology
19.12.2018 | Physics and Astronomy
19.12.2018 | Life Sciences